DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Wyles D, Bräu N, Kottilil S. , et al; ASTRAL-5 Investigators.
ASTRAL-5 Investigators. Sofosbuvir and velpatasvir for the treatment of hepatitis C virus in patients coinfected with human immunodeficiency virus type 1: an open-label, phase 3 study.
Clin Infect Dis 2017;
65 (01) 6-12
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.